logo
15:59 Feb 25

Natco Pharma Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
978.20
+33.35 (+3.53%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Natco Pharma Ltd. Financials

Natco Pharma Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
978.20
+33.35 (+3.53%)
15:59 Feb 25
Quality
image/svg+xml

66/100
High Financial Strength

Valuation
image/svg+xml

44/100
Mid Valuation

Technical

53/100
Technically Neutral

Strength

12

Weakness

3

Opportunity

1

Threats

1

24.78 %

ROE %

21.84 %

ROA %

86.94

EPS

424.97

BVPS

42.56 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
1944.8 2707.1 3998.8 4429.5 4560.2
Operating Expenses +
1681.3 1771.5 2247.4 2233.5 2703.2
Raw Material
577.7 651 673.9 702.3 866.2
Increase Decrease in Cost
-16.8 -23.7 42.7 -12.5 -81.2
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
444.8 486.7 525 594.5 688.1
Miscellaneous Expenses
792.6 1008.9 1308.6 1281.4 1230.1
Operating Profit
263.5 935.6 1751.4 2196 1857
Other Income
99 104.6 128.1 354.5 286.1
Depreciation
142.6 163.8 186.8 235.2 254.5
Interest
17.7 14.5 19.2 23.9 36
Profit before tax and exceptio..
202.2 861.9 1673.5 2291.4 1852.6
Exceptional Items
0 0 0 0 0
PBT
202.2 861.9 1673.5 2291.4 1852.6
Provision for Taxation
32.2 146.6 285.2 408 308
Net Profit
170 715.3 1388.3 1883.4 1544.6
NET Profit after MI
170 715.3 1388.3 1885.4 1557.2
EPS
9.32 39.18 77.34 105.26 86.94
Operating Profit Margin (%)
13.55 34.56 43.8 49.58 40.72
Net Profit Margin (%)
8.74 26.42 34.72 42.56 34.15

Natco Pharma Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Promoter 49.50 49.50 49.60 49.60 49.60 49.60
FII 15.20 14.10 15.50 17.50 17.90 17.50
Public 5.40 5.90 5.80 5.60 5.60 6.80
Others 29.90 30.50 29.10 27.30 26.90 26.10
Shareholder Shares Holding %
Research 360 logo
Download Our App On: